Saturn V Capital Management as of Dec. 31, 2025
Portfolio Holdings for Saturn V Capital Management
Saturn V Capital Management holds 20 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abivax Sa Sponsored Ads (ABVX) | 16.1 | $88M | 649k | 134.85 | |
| Amylyx Pharmaceuticals (AMLX) | 10.0 | $54M | 4.5M | 12.08 | |
| Cogent Biosciences (COGT) | 7.9 | $43M | 1.2M | 35.52 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 7.7 | $42M | 248k | 170.00 | |
| Vaxcyte (PCVX) | 6.8 | $37M | 799k | 46.14 | |
| Dyne Therapeutics (DYN) | 6.4 | $35M | 1.8M | 19.56 | |
| Pharvaris N V (PHVS) | 5.8 | $32M | 1.1M | 27.75 | |
| Celcuity (CELC) | 5.8 | $32M | 317k | 99.74 | |
| Alumis (ALMS) | 5.6 | $31M | 3.1M | 9.76 | |
| Disc Medicine (IRON) | 4.3 | $24M | 298k | 79.41 | |
| X4 Pharmaceuticals Com New (XFOR) | 4.3 | $23M | 5.8M | 4.00 | |
| Monopar Therapeutics Com New (MNPR) | 3.9 | $21M | 326k | 65.30 | |
| Adagio Therapeutics (IVVD) | 3.5 | $19M | 7.7M | 2.47 | |
| Ocular Therapeutix (OCUL) | 3.4 | $18M | 1.5M | 12.14 | |
| Immix Biopharma (IMMX) | 2.9 | $16M | 3.0M | 5.23 | |
| Oculis Holding Ordinary Shares (OCS) | 1.9 | $10M | 517k | 19.97 | |
| Inhibikase Therapeutics Com New (IKT) | 1.5 | $7.9M | 3.9M | 2.05 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.3 | $7.1M | 283k | 25.01 | |
| Ovid Therapeutics (OVID) | 0.7 | $4.1M | 2.5M | 1.63 | |
| Inventiva Sa Ads (IVA) | 0.2 | $1.3M | 283k | 4.65 |
